Skip to main content
Premium Trial:

Request an Annual Quote

Doug Berthiaume, Juan Herrero, William Radany, Kirk Collamer, Terry Salyer, Claire Fraser-Liggett

Waters CEO Doug Berthiaume has given a $5 million award to the Isenberg School of Management at the University of Massachusetts Amherst.
 
The funds will help kick off a $350 million capital campaign, UMass said in a statement.
 

 
Proteopure has hired Juan Herrero as vice president of marketing and business development.
 
Herrero was previously an executive associate with the Pittsburgh Life Sciences Greenhouse. Prior to that, he served as vice president of life science and drug discovery at Fisher Scientific International. He also held several positions at AxCell Biosciences, including assistant director of molecular biology and senior director of operations.
 
Herrero holds a PhD in microbiology and molecular genetics, a master’s degree in molecular biology, and an MBA.
 

 
William Radany has joined HTG as CEO. He replaces Kirk Collamer, who will remain with the company as CFO.
 
Radany joins the firm from Chemicon International. Prior to that, he was chief business officer at Xencor and served as vice president of drug discovery programs at both Caliper Technologies and Stratagene and as president of Biacore.
 
Radany holds a BS in cell biology from Colorado State University and a PhD in biochemistry/physiology from the University of Wyoming.
 

 
Terry Salyer has joined Eksigent as vice president of sales and service, the firm announced this week. Salyer joins Eksigent from Molecular Devices, where she served as director of sales for three divisions. She will be responsible for global sales and customer support activities and for expanding Eksigent’s international distribution network.
 

 
Claire Fraser-Liggett will join the board of directors of Becton Dickinson,effective Nov. 20, the firm announced this week. Fraser-Liggett is president and director of The Institute for Genomic Research.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.